10 unknown. 10 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Unknown 10 |
| Phase 2 | 1 | Unknown 1 |
Follow Bleomycin: new trials by email Literature Review of Bleomycin trials Research Report on Bleomycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL Rituximab, Etoposide, Doxorubicin - Lymphoma, Large B-Cell, Diffuse | Phase 3 | Unknown | Nanfang Hospital, Southern Medical University | 402 | 2017-07-27 | 2017-07-28 |
| HD21 for Advanced Stages Bleomycin, Etoposide, Doxorubicin - Classical Hodgkin Lymphoma | Phase 3 | Unknown | University of Cologne | 1500 | 2016-07-01 | 2024-05-13 |
| Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma R-mabHDI and ABVD, ABVD - Hodgkin's Lymphoma | Phase 3 | Unknown | American Scitech International | 1200 | 2011-07-01 | 2011-07-20 |
| HD16 for Early Stage Hodgkin Lymphoma ABVD (Adriamycin, Bleomycin, Vincristine, Dacarbazine), 20 Gy IFRT (Involved Field Radiotherapy) - Hodgkin Lymphoma | Phase 3 | Unknown | University of Cologne | 1150 | 2009-11-01 | 2020-11-04 |
| Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors bleomycin sulfate, carboplatin, cisplatin - Childhood Germ Cell Tumor, Extragonadal Germ Cell Tumor | Phase 3 | Unknown | Children's Cancer and Leukaemia Group | 105 | 2005-05-01 | 2013-09-17 |
| Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Hodgkin's Lymphoma bleomycin sulfate, ABVD regimen, Stanford V regimen - Lymphoma | Phase 3 | Unknown | Mount Vernon Cancer Centre at Mount Vernon Hospital | 850 | 2001-10-01 | 2013-09-20 |
| Combination Chemotherapy in Treating Men With Germ Cell Cancer bleomycin sulfate, filgrastim, cisplatin - Extragonadal Germ Cell Tumor, Teratoma | Phase 2 / Phase 3 | Unknown | European Organisation for Research and Treatment of Cancer - EORTC | 498 | 1998-10-01 | 2012-03-06 |
| Combination Chemotherapy Given With Radiation Therapy or Radiation Therapy Alone in Treating Patients With Early-Stage Hodgkin's Disease bleomycin sulfate, cyclophosphamide, doxorubicin hydrochloride - Lymphoma | Phase 3 | Unknown | Medical Research Council | 400 | 1997-01-01 | 2013-12-04 |
| Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma bleomycin sulfate, carmustine, cyclophosphamide - Lymphoma | Phase 3 | Unknown | Scotland and Newcastle Lymphoma Group | 1994-06-01 | 2013-09-17 | |
| A Comparison of DOX-SL Versus Adriamycin Plus Bleomycin Plus Vincristine in the Treatment of Severe AIDS-Related Kaposi's Sarcoma Doxorubicin hydrochloride (liposomal), Bleomycin sulfate, Vincristine sulfate - Sarcoma, Kaposi, HIV Infections | Phase 3 | Unknown | Sequus Pharmaceuticals | 225 | 2005-06-24 |
Hodgkin Disease (4) · Lymphoma (3) · Lymphoma, Large B-Cell, Diffuse (2) · Teratoma (2) · Testicular Neoplasms (2) · Acquired Immunodeficiency Syndrome (1) · Carcinoma, Embryonal (1) · Endodermal Sinus Tumor (1) · HIV Infections (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Non-Hodgkin (1) · Ovarian Germ Cell Cancer (1) · Ovarian Neoplasms (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Sarcoma, Kaposi (1)
University of Cologne (2) · American Scitech International (1) · Children's Cancer and Leukaemia Group (1) · European Organisation for Research and Treatment of Cancer - EORTC (1) · Medical Research Council (1) · Mount Vernon Cancer Centre at Mount Vernon Hospital (1) · Nanfang Hospital, Southern Medical University (1) · Scotland and Newcastle Lymphoma Group (1) · Sequus Pharmaceuticals (1)
United Kingdom (5) · Germany (3) · United States (2) · Austria (1) · Belgium (1) · China (1) · Denmark (1) · France (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1) · Netherlands (1) · Norway (1) · Poland (1)
Andreas Engert, Prof. (1) · Juliet Hale, MD (1) · Michael Williams, MD (1) · Peter Borchmann, Prof. (1) · Peter J. Hoskin, MD (1) · Ratna Grewal, MD. (1) · Ronald De Wit, MD, PhD (1) · Ru Feng, M.D. (1) · Sarath Babu, MD. (1) · Stephen J. Proctor, MD, FRCP, FRCPath (1)
PMID 40135712, PMID 25964643, PMID 30010775, PMID 31498753, PMID 35717166, PMID 38971175, PMID 40652943, PMID 40674676, PMID 41074963, PMID 42379221
2014 (1)